Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04679675 · ClinicalTrials.gov registry record · NA
Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 32,771
- Enrollment target
NCT04679675: Completed NA study, sponsored by Kaiser Permanente.
NCT04679675 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 32,771 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2236% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04679675, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 32,771 participants
- Enrollment target
Study Summary
The Self-Testing options in the Era of Primary HPV screening for cervical cancer (STEP) trial will evaluate effectiveness of home-based HPV kits for improving cervical cancer screening uptake and its cost-effectiveness. The investigators will compare cervical cancer screening uptake within six months among women randomized to different outreach approaches based on prior screening behavior: A) Adherent and coming due: direct mail HPV kit vs. opt-in HPV kit vs. education; B) Overdue: direct mail HPV kit vs. education; C) Unknown: opt-in HPV kit vs. education.
Primary Outcome
Rate of completing cervical cancer screening completion by outreach approach and prior screening behavior. Screening completion defined by returning the home kit and attending the recommended in clinic follow-up (if applicable); or receiving in clinic screening.
Interventions
- OTHER Usual Care
- BEHAVIORAL Education
- BEHAVIORAL Direct Mail
- BEHAVIORAL Opt-in
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32,771 participants |
| Start Date | 2020-11-20 |
| Est. Completion | 2023-07-29 |
| Phase | NA |
What the finished NCT04679675 record still lists
NCT04679675 is an interventional study that assigns participants to a tested intervention. Its 32,771 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (2236% higher).
The record links to 0 conditions, and to 4 interventions - of which Usual Care is the first listed.
NCT04679675 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04679675 about?
NCT04679675 is a clinical study titled "Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial". The Self-Testing options in the Era of Primary HPV screening for cervical cancer (STEP) trial will evaluate effectiveness of home-based HPV kits for improving cervical cancer screening uptake and its cost-effectiveness. The investigators will compare cervical cancer screening uptake within six month...
What is the current status of trial NCT04679675?
This trial is currently completed. It is a NA study. The enrollment target is 32,771 participants. The study started on 2020-11-20. Estimated completion is 2023-07-29.
What interventions are being tested in trial NCT04679675?
The interventions under investigation include: Usual Care (OTHER), Education (BEHAVIORAL), Direct Mail (BEHAVIORAL), Opt-in (BEHAVIORAL).
Who is sponsoring clinical trial NCT04679675?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04679675's enrollment target sits among peer trials
32,771 8th of 2000 higher than 1,993 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI